Pharmacy Report Archives - Page 20 of 150 - Becker's Hospital Review

FDA warns drugmakers over ads | Specialty pharmacy group issues awards | 10 systems seeking pharmacy leaders | Inside Montefiore's meds-to-beds program | 5 new hospital pharmacies

September 18, 2025 1. 8 systems, leaders receive specialty pharmacy awards Full story 2. FDA warns drugmakers over advertising practices Full story 3. Prior auth bottlenecks hurt access. Fix handoffs with automation here. 4. Montefiore program improves cholesterol therapy uptake…

4 new drug shortages | OhioHealth finishes $3.15M pharmacy | Pharma execs lean into genomics | St. Jude tests 3D-printed drugs | Optum Rx ups reimbursements for local pharmacies

September 17, 2025 1. 4 drugs in shortage Full story 2. OhioHealth hospital grows pharmacy with $3.15M expansion Full story 3. Margins are under pressure. Innovation is on the rise. Discover how the nation's top CPOs are balancing both at…

Hospitals decry 340B 'clawback' plan | Former Providence CPO joins drugmaker | Court upholds Miss. 340B law | Big 3 PBM reliance shrinks | Ill. hospital CEO dismissed

September 16, 2025 1. Health systems push back on CMS' proposed 340B changes Full story 2. Former Providence pharmacy chief joins drugmaker Full story 3. Prior auth bottlenecks hurt access. Fix handoffs with automation here. 4. Reliance on Big 3…

7 new drug shortages | Pressure mounts against HHS' 340B pilot | GLP-1 approvals: A breakdown | FDA reduces drug review panels | 10 leading causes of death: CDC

September 15, 2025 1. Pressure mounts against HHS' 340B pilot: 5 notes Full story 2. 7 drugs in shortage Full story 3. NewYork-Presbyterian boosted infusion appointments by 21% — the scheduling changes behind it here. 4. FDA moves to cut expert…

340B drug spending skyrockets: CBO | CVS shakes up exec suite | 10 systems seeking pharmacy leaders | Gene therapy trial halted after patient death | Generics exempt in US-Japan tariffs deal

September 11, 2025 1. 340B drug spending up 565% over 11 years: CBO Full story 2. CVS Health reshapes care delivery leadership Full story 3. Margins are under pressure. Innovation is on the rise. Discover how the nation's top CPOs…

US might restrict China-made drugs | FDA cracks down on drug ads | CVS settles with Okla. for $32M | 12 fastest-growing healthcare jobs | GLP-1s reduce fracture risks: Study

September 10, 2025 1. Trump administration eyes crackdown on Chinese drugs Full story 2. HHS, FDA to crack down on drug ads Full story 3. Hartford HealthCare is using AI to optimize nurse shifts & retention. Learn how — live…

Top policy issues for pharmacy leaders | AHA urges federal probe of 340B rebates | Amazon Pharmacy expands to Texas | Allina closes hospital infusion center | GLP-1s added to WHO's essential medicine list

September 9, 2025 1. 3 policy issues on pharmacy leaders' radar Full story 2. AHA urges federal probe of 340B rebate models: 5 notes Full story 3. How NewYork-Presbyterian is aligning metrics + workflows across infusion centers: here. 4. Amazon…

Trump edits pharma tariffs: 5 notes | Are prescriptions fueling rising fall deaths? | 3 GLP-1 updates | CVS sued over Zepbound change | UVA Health hits pharmacy milestone

September 8, 2025 1. Trump eyes easing tariffs on pharmaceuticals: 5 notes Full story 2. Wegovy gains new approval: 3 GLP-1 updates Full story 3. Margins are under pressure. Innovation is on the rise. Discover how the nation's top CPOs…

FDA warns Amneal of 'significant violations' | Common nasal spray lowers COVID risk in study | 10 systems seeking pharmacy leaders | Hospital drug costs soar | Managers stretched thin

September 4, 2025 1. FDA slams Amneal for 'significant violations' in warning letter Full story 2. Common nasal spray may lower COVID-19 risk: Study Full story 3. Prior auth bottlenecks hurt access. Fix handoffs with automation here. 4. Repurposed drugs…

Real-time drug pricing rule to take effect | Cigna invests $3.5B in specialty pharma co. | Weekly Alzheimer's drug approved | COVID activity rises amid vaccine uncertainty | Federal PBM probe widens

September 3, 2025 1. Real-time drug pricing access rule to take effect Full story 2. Trump demands COVID 'drug' data from pharmaceutical companies Full story 3. How Prisma Health is delivering upfront cost clarity for patients — here. 4. FDA…